Clinical Trial Update: Strategies for Transfusion of Platelets (SToP) [Phase 3]

View source ↗

Summary

The SToP Phase 3 trial evaluating platelet transfusion strategies for thrombocytopenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Thrombocytopenia | Phase 3 | Status: TERMINATED